Dr. Adrian Carter is an NHMRC Career Development and Senior Research Fellow and Head, Neuroethics and Public Policy Group at the School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University. He is also Director, Neuroethics Program, Australian Research Council Centre of Excellence for Integrative Brain Function and Chair, Australian Brain Alliance Neuroethics Subcommittee, Australian Academy of Science. His research examines the impact of neuroscience on our understanding and treatment of addiction and other compulsive behaviours, including: agency, identity, moral responsibility, the use of coercion and the capacity for voluntary control of addictive or compulsive behaviours; and the use of emerging technologies such as brain stimulation and neuroimaging, to treat addiction. He received the Australasian Professional Society of Alcohol and Other Drugs “Early Career Award for Excellence in Research and Science” (2012) and the Australian National Drug and Alcohol Award for Excellence in Research (2010). He has over 120 publications, including the book ‘Addiction Neuroethics: The Promises and Perils of Addiction Neuroscience’ (Cambridge University Press, 2012). Dr Carter has been an advisor to the World Health Organization, the European Monitoring Centre for Drugs and Drug Addiction, the Australian Ministerial Council on Drugs Strategy and United Nations Office on Drugs and Crime. He is also Deputy Chair of the Australian Academy of Science Early and Mid Career Research Forum Executive.
Arisa Ema is the Assistant Professor at the University of Tokyo and Visiting Researcher at RIKEN Center for Advanced Intelligence Project in Japan. She is a researcher in Science and Technology Studies (STS), and her primary interest is to investigate the benefits and risks of artificial intelligence by organizing an interdisciplinary research group. She is a co-founder of the Acceptable Intelligence with Responsibility Study Group (AIR), established in 2014, which seeks to address emerging issues and relationships between artificial intelligence and society. She is a member of the Ethics Committee of the Japanese Society for Artificial Intelligence (JSAI), which released the Japanese Society for Artificial Intelligence Society Ethical Guidelines in 2017. She is also one of the organizers of the 2017 “IEEE Ethically Aligned Design, Version 1 Workshop in Japan.” She obtained her Ph.D. from the University of Tokyo in 2012 and previously held a position as Assistant Professor at the Hakubi Center for Advanced Research, Kyoto University.
Tamami Fukushi is Deputy Manager in the Department of Research Infrastructure at Japan Agency for Medical Research and Development (AMED). She graduated Nara Women’s University (Physical Education) and Graduate School of Science, Kyoto University (Primatology) then took Ph.D. in Behavioral Science at Department of Psychology, Hokkaido University in March 1999. Defended thesis in the field of neuroscience on an experimental investigation of neural function of non-human primate frontal cortex during visually guided isometric force production task. From 1999 to 2005, she worked for Department of Neuroscience, University of Minnesota as Postdoctoral/Research Associate for motor control research focusing on human and non-human primates.
She started career in Neuroethics in 2005 when she moved back to Japan at the Research Institute of Science and Technology for Society (RISTEX), Japan Science and Technology Agency (JST) as a researcher of cohort project called “Japan Children’s Study Group”. She organized the first international symposium of neuroethics in Asian region in July 2006 in Tokyo, and contributed to dissemination of neuroethics to Japanese and Asian stakeholders. After closing the cohort project in 2009, she experienced science policy at Center for Research and development Strategies (CRDS) in JST and regulatory science at Pharmaceuticals and Medical Devices Agency (PMDA). During those years, she extended her career to science policy making and international cooperation policy in life science and medicines. In June 2017, she joined Japan Agency for Medical Research and Development (AMED) as policy and information analyst.
Her current interest of neuroethics is ELSI of advanced technology of neuroscience in the context of science policy and regulatory science. She is the first author of the book chapter entitled “Neuroethics in Japan” In: Johnson, L.S.M. and Rommelfanger, K., (eds.) Handbooks in Neuroethics. Routledge Pp.442-456. She also co-authored the Perspective paper entitled “Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives” in Neuron 100 (October 10), Pp.19-36, 2018.
Dr. Illes is Professor of Neurology and Canada Research Chair in Neuroethics at UBC. She is Director of Neuroethics Canada, and faculty in the Centre for Brain Health and at the Vancouver Coastal Health Research Institute. She received her PhD in Hearing and Speech Sciences, and in Neuropsychology at Stanford University, and became one of the pioneers of the field of neuroethics formally established in early 2000.
Dr. Illes’ research, teaching and outreach initiatives are devoted to ethical, legal, social and policy challenges at the intersection of the brain sciences and biomedical ethics. She has made groundbreaking contributions to neuroethical thinking for neuroscience discovery and clinical translation specifically in the areas of neuromodulation, neuropsychiatry, neurodevelopment, and neurodegeneration, and more broadly to entrepreneurship and the commercialization of health care.
In addition to her primary appointment in the Faculty of Medicine at UBC, Dr. Illes also holds associate appointments in Population and Public Health and in Journalism at UBC, and in the Department of Computer Science and Engineering at the University of Washington in Seattle, WA, USA. She is Vice Chair of the Standing Committee on Ethics of the Canadian Institutes of Health Research (CIHR), and Vice Chair of the CIHR’s Internal Advisory Board of the Institute on Neuroscience, Mental Health and Addiction.
Dr. Illes received the Order of Canada, the country’s highest civilian award, in December 2017. She was elected to the Canadian Academy of Health Sciences in 2011, Royal Society of Canada in 2012, and to the American Association for the Advancement of Science (Division of Neuroscience) in 2013. She is immediate past President of the International Neuroethics Society, founded in 2006. She is also an elected member of the International Women’s Forum. Her latest books, a series on Developments in Neuroethics and Bioethics, feature pain, global mental health, and do-it-yourself brain devices.
Dr. Illes writes frequently for the Vancouver Sun and Canada’s The Conversation Canada, and hosts community outreach about challenging ethical problems involving biomedicine and the brain throughout BC and across the country.
Ilina Singh is Professor of Neuroscience & Society at the University of Oxford, where she holds a joint appointment between the Department of Psychiatry and the Faculty of Philosophy (Oxford Centre for Neuroethics and Oxford Uehiro Centre for Practical Ethics). Her work examines the psychosocial and ethical implications of advances in biomedicine and neuroscience for young people and families. Recent projects include the ADHD VOICES project (www.adhdvoices.com); Neuroenhancement Responsible Research and Innovation (www.nerri.eu); and the Urban Brain Project (www.urbanbrainlab.com). In 2014, Professor Singh received a Wellcome Trust Senior Investigator Award for a study entitled: Becoming Good: Early Intervention and Moral Development in Child Psychiatry.
Professor Singh has published widely in eminent journals, including Nature, Nature Reviews Neuroscience, Social Science and Medicine, and the American Journal of Bioethics. She is the lead editor of a new volume: BioPrediction, Biomarkers and Bad Behavior: Scientific, Ethical and Legal Challenges (co-edited with Walter-Sinnott Armstrong and Julian Savulescu), published by Oxford University Press. She has acted as an advisor to the Nuffield Council on Bioethics, NICE, NIMH and other organisations. She is co-editor of the journal BioSocieties and on the editorial board of the American Journal of Bioethics-Neuroscience and Qualitative Psychology.
Jialin Charles Zheng
Jialin Zheng is Dean of the Tongji University School of Medicine, where he is a Professor of Neuroscience and Regenerative Medicine. He is simultaneously a Professor of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center (UNMC). Dr. Zheng’s research focuses on the understanding and treatment of neurodegenerative disorders such as Parkinson’s Disease. Ultimately it is the mission of his lab to develop drugs that will inhibit neurotoxin production and enhance neuronal repair in the brain. Dr. Zheng has been at the fore of UNMC’s collaborative efforts in China. He is the Director of UNMC’s Asia Pacific Rim Development Program and has worked to create more than 10 partnerships in China, including the formation of the first joint U.S./Chinese M.D./Ph.D. program. Dr. Zheng received his M.D. from Xuzhou Medical College in China and served as a visiting scholar at the State University of New York at Buffalo prior to joining UNMC.